Literature DB >> 21987408

Adverse effects of hyperlipidemia on bone regeneration and strength.

Flavia Pirih1, Jinxiu Lu, Fei Ye, Olga Bezouglaia, Elisa Atti, Maria-Grazia Ascenzi, Sotirios Tetradis, Linda Demer, Tara Aghaloo, Yin Tintut.   

Abstract

Hyperlipidemia increases the risk for generation of lipid oxidation products, which accumulate in the subendothelial spaces of vasculature and bone. Atherogenic high-fat diets increase serum levels of oxidized lipids, which are known to attenuate osteogenesis in culture and to promote bone loss in mice. In this study, we investigated whether oxidized lipids affect bone regeneration and mechanical strength. Wild-type (WT) and hyperlipidemic (Ldlr(-/-)) mice were placed on a high-fat (HF) diet for 13 weeks. Bilateral cranial defects were introduced on each side of the sagittal suture, and 5 weeks postsurgery on the respective diets, the repair/regeneration of cranial bones and mechanical properties of femoral bones were assessed. MicroCT and histological analyses demonstrated that bone regeneration was significantly impaired by the HF diet in WT and Ldlr(-/-) mice. In femoral bone, cortical bone volume fraction (bone volume [BV]/tissue volume [TV]) was significantly reduced, whereas cortical porosity was increased by the HF diet in Ldlr(-/-) but not in WT mice. Femoral bone strength and stiffness, measured by three-point bending analysis, were significantly reduced by the HF diet in Ldlr(-/-), but not in WT mice. Serum analysis showed that the HF diet significantly increased levels of parathyroid hormone, tumor necrosis factor (TNF)-α, calcium, and phosphorus, whereas it reduced procollagen type I N-terminal propeptide, a serum marker of bone formation, in Ldlr(-/-), but not in WT mice. The serum level of carboxyl-terminal collagen crosslinks, a marker for bone resorption, was also 1.7-fold greater in Ldlr(-/-) mice. These findings suggest that hyperlipidemia induces secondary hyperparathyroidism and impairs bone regeneration and mechanical strength.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21987408      PMCID: PMC3274629          DOI: 10.1002/jbmr.541

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  47 in total

1.  Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men.

Authors:  Michael Schoppet; Juergen R Schaefer; Lorenz C Hofbauer
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

2.  8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway.

Authors:  Yin Tintut; Farhad Parhami; Anastasia Tsingotjidou; Sotirios Tetradis; Mary Territo; Linda L Demer
Journal:  J Biol Chem       Date:  2002-02-04       Impact factor: 5.157

3.  Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells.

Authors:  F Parhami; S M Jackson; Y Tintut; V Le; J P Balucan; M Territo; L L Demer
Journal:  J Bone Miner Res       Date:  1999-12       Impact factor: 6.741

4.  Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids.

Authors:  Andrew P Sage; Jinxiu Lu; Elisa Atti; Sotirios Tetradis; Maria-Grazia Ascenzi; Douglas J Adams; Linda L Demer; Yin Tintut
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

5.  Increased osteoprotegerin serum levels in men with coronary artery disease.

Authors:  Michael Schoppet; Alexander M Sattler; Juergen R Schaefer; Matthias Herzum; Bernhard Maisch; Lorenz C Hofbauer
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

6.  High-fat, high-cholesterol diet increases the incidence of gastritis in LDL receptor-negative mice.

Authors:  A Laurila; S P Cole; S Merat; M Obonyo; W Palinski; J Fierer; J L Witztum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-06       Impact factor: 8.311

7.  Oxidative stress modulates osteoblastic differentiation of vascular and bone cells.

Authors:  N Mody; F Parhami; T A Sarafian; L L Demer
Journal:  Free Radic Biol Med       Date:  2001-08-15       Impact factor: 7.376

8.  Atherogenic high-fat diet reduces bone mineralization in mice.

Authors:  F Parhami; Y Tintut; W G Beamer; N Gharavi; W Goodman; L L Demer
Journal:  J Bone Miner Res       Date:  2001-01       Impact factor: 6.741

9.  Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.

Authors:  Katherine Esposito; Francesco Nappo; Raffaele Marfella; Giovanni Giugliano; Francesco Giugliano; Myriam Ciotola; Lisa Quagliaro; Antonio Ceriello; Dario Giugliano
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

10.  Oxidized lipid depresses canine growth, immune function, and bone formation.

Authors:  John J Turek; Bruce A Watkins; Ingrid A Schoenlein; Kenneth G D Allen; Michael G Hayek; C Gregory Aldrich
Journal:  J Nutr Biochem       Date:  2003-01       Impact factor: 6.048

View more
  37 in total

1.  Role of paraoxonase-1 in bone anabolic effects of parathyroid hormone in hyperlipidemic mice.

Authors:  Jinxiu Lu; Henry Cheng; Elisa Atti; Diana M Shih; Linda L Demer; Yin Tintut
Journal:  Biochem Biophys Res Commun       Date:  2013-01-03       Impact factor: 3.575

2.  Hyperlipidemia affects multiscale structure and strength of murine femur.

Authors:  Maria-Grazia Ascenzi; Andre Lutz; Xia Du; Laureen Klimecky; Neal Kawas; Talia Hourany; Joelle Jahng; Jesse Chin; Yin Tintut; Udo Nackenhors; Joyce Keyak
Journal:  J Biomech       Date:  2014-04-16       Impact factor: 2.712

3.  Protective Role of Smad6 in Inflammation-Induced Valvular Cell Calcification.

Authors:  Xin Li; Jina Lim; Jinxiu Lu; Taylor M Pedego; Linda Demer; Yin Tintut
Journal:  J Cell Biochem       Date:  2015-10       Impact factor: 4.429

Review 4.  Anorexia nervosa, obesity and bone metabolism.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Pediatr Endocrinol Rev       Date:  2013-09

5.  Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis.

Authors:  C-H Chen; C-L Lin; C-H Kao
Journal:  Osteoporos Int       Date:  2016-02-10       Impact factor: 4.507

6.  The promotion of bone healing by progranulin, a downstream molecule of BMP-2, through interacting with TNF/TNFR signaling.

Authors:  Yun-peng Zhao; Qing-yun Tian; Sally Frenkel; Chuan-ju Liu
Journal:  Biomaterials       Date:  2013-06-05       Impact factor: 12.479

7.  Hyperlipidemia compromises homing efficiency of systemically transplanted BMSCs and inhibits bone regeneration.

Authors:  Quan-Chen Xu; Peng-Jie Hao; Xin-Bo Yu; Shu-Lan Chen; Mei-Jiao Yu; Jin Zhang; Pi-Shan Yang
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

8.  The effects of hyperlipidemia on implant osseointegration in the mouse femur.

Authors:  Armand Keuroghlian; Ana Dilza Viana Barroso; Gary Kirikian; Olga Bezouglaia; Yin Tintut; Sotirios Tetradis; Peter Moy; Flavia Pirih; Tara Aghaloo
Journal:  J Oral Implantol       Date:  2013-12-02       Impact factor: 1.779

Review 9.  The relevance of mouse models for investigating age-related bone loss in humans.

Authors:  Robert L Jilka
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-05-20       Impact factor: 6.053

10.  Effects of teriparatide on morphology of aortic calcification in aged hyperlipidemic mice.

Authors:  Jeffrey J Hsu; Jinxiu Lu; Soban Umar; Jason T Lee; Rajan P Kulkarni; Yichen Ding; Chih-Chiang Chang; Tzung K Hsiai; Akishige Hokugo; Ioannis Gkouveris; Sotirios Tetradis; Ichiro Nishimura; Linda L Demer; Yin Tintut
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-02-16       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.